Evidence map›Paper›PMID 23560677›Full record

ArticleBiochemistry2013

Mycobacterium tuberculosis utilizes a unique heterotetrameric structure for dehydrogenation of the cholesterol side chain.

Suzanne T Thomas, Nicole S Sampson

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Targeted Mutagenesis of Mycobacterium Strains by Homologous Recombination.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  9. Article
  10. The unusual convergence of steroid catabolic pathways inProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  11. Article
  12. Article
  13. Comparative Analysis of Bile-Salt Degradation inApplied and environmental microbiology · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Structural basis for the broad substrate specificity of two acyl-CoA dehydrogenases FadE5 from mycobacteria.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  19. Article
  20. Biochemistry · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Suzanne T ThomasDepartment of Chemistry, Stony Brook University, Stony Brook, NY 11794, USA.
Nicole S Sampson
Stony Brook University · US

Funding

CHOLESTEROL OXIDASE LOOP RESIDUES &CATALYSISR01HL053306 · NHLBI · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S · 2001 to 2009
$2.6M
Steroid Hormone Biosynthesis by M.tbR21AI092455 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S · 2011 to 2012
$425k
MALDI-TOF SPECTROM: PROTEIN: INHIBIT FATTY ACID BIOSYNTHESIS IN M TUBERCULOSISS10RR021008 · NCRR · STATE UNIVERSITY NEW YORK STONY BROOK · PI SAMPSON, NICOLE S. · 2005 to 2005
$270k
NCRR NIH HHS S10 RR021008NCRR NIH HHS S10RR021008NHLBI NIH HHS R01 HL053306NHLBI NIH HHS R01HL53306NIAID NIH HHS R21 AI092455NIAID NIH HHS R21AI092455
6 · The paper itself

Abstract

Compounding evidence supports the important role in pathogenesis that the metabolism of cholesterol by Mycobacterium tuberculosis plays. Elucidating the pathway by which cholesterol is catabolized is necessary to understand the molecular mechanism by which this pathway contributes to infection. On the basis of early metabolite identification studies in multiple actinomycetes, it has been proposed that cholesterol side chain metabolism requires one or more acyl-CoA dehydrogenases (ACADs). There are 35 genes annotated as encoding ACADs in the M. tuberculosis genome. Here we characterize a heteromeric ACAD encoded by Rv3544c and Rv3543c, formerly named fadE28 and fadE29, respectively. We now refer to genes Rv3544c and Rv3543c as chsE1 and chsE2, respectively, in recognition of their validated activity in cholesterol side chain dehydrogenation. Analytical ultracentrifugation and liquid chromatography-ultraviolet experiments establish that ChsE1-ChsE2 forms an α(2)β(2) heterotetramer, a new architecture for an ACAD. Our bioinformatic analysis and mutagenesis studies reveal that heterotetrameric ChsE1-ChsE2 has only two active sites. E241 in ChsE2 is required for catalysis of dehydrogenation by ChsE1-ChsE2. Steady state kinetic analysis establishes the enzyme is specific for an intact steroid ring system versus hexahydroindanone substrates with specificity constants (k(cat)/K(M)) of (2.5 ± 0.5) × 10(5) s(-1) M(-1) versus 9.8 × 10(2) s(-1) M(-1), respectively, at pH 8.5. The characterization of a unique ACAD quaternary structure involved in sterol metabolism that is encoded by two distinct cistronic ACAD genes opens the way to identification of additional sterol-metabolizing ACADs in M. tuberculosis and other actinomycetes through bioinformatic analysis.

Indexed as

Acyl-CoA DehydrogenaseBiophysicsBiopolymersCholesterolChromatography, GelHydrogenationMycobacterium tuberculosisNuclear Magnetic Resonance, BiomolecularPlasmidsSpectrophotometry, UltravioletAcyl-CoA DehydrogenaseBiopolymersCholesterol

Identifiers

PMID23560677
PMCPMC3726044
OpenAlexW2026710113

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.